These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 4054071)
21. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase. Toki N; Takasugi S; Ishizu K; Sato H; Sumi H Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043 [TBL] [Abstract][Full Text] [Related]
22. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase. Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852 [TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels. Asakura H; Asamura R; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Yoshida T; Miyamoto K; Nakao S Thromb Haemost; 2005 Apr; 93(4):724-8. PubMed ID: 15841319 [TBL] [Abstract][Full Text] [Related]
24. Coagulation and fibrinolysis in rats poisoned with mercuric chloride. Michalska M; Mirowski M; Wierzbicki R Pol J Pharmacol Pharm; 1988; 40(4):365-71. PubMed ID: 3146750 [TBL] [Abstract][Full Text] [Related]
25. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin]. Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687 [TBL] [Abstract][Full Text] [Related]
26. Immobilization of plasminogen activator, urokinase, on nylon. Sugitachi A; Takagi K; Imaoka S; Kosaki G Thromb Haemost; 1978 Apr; 39(2):426-36. PubMed ID: 580991 [TBL] [Abstract][Full Text] [Related]
27. Urokinase quality: analysis of different preparations. Rogatti W; Yokoigawa K; Kobayashi T Thromb Haemost; 1985 Apr; 53(2):245-8. PubMed ID: 4024035 [TBL] [Abstract][Full Text] [Related]
28. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Korninger C; Collen D Thromb Haemost; 1981 Aug; 46(2):561-5. PubMed ID: 6795744 [TBL] [Abstract][Full Text] [Related]
29. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis. van Giezen JJ; Boon GI; Jansen JW; Bouma BN Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851 [TBL] [Abstract][Full Text] [Related]
30. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582 [TBL] [Abstract][Full Text] [Related]
31. The transport of 125I-labeled human high molecular weight urokinase across the intestinal tract in a dog model with stimulation of synthesis and/or release of plasminogen activators. Sasaki K; Moriyama S; Tanaka Y; Sumi H; Toki N; Robbins KC Blood; 1985 Jul; 66(1):69-75. PubMed ID: 4039958 [TBL] [Abstract][Full Text] [Related]
32. [Fibrinolytic activity of acyl-urokinase]. Stürzebecher J; Kroneck I; Klöcking HP Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):137-43. PubMed ID: 2427394 [TBL] [Abstract][Full Text] [Related]
33. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA]. Ieko M Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator. de Munk GA; Groeneveld E; Rijken DC Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553 [TBL] [Abstract][Full Text] [Related]
35. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site. Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727 [TBL] [Abstract][Full Text] [Related]
36. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. Glas-Greenwalt P; Kant KS; Allen C; Pollak VE J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000 [TBL] [Abstract][Full Text] [Related]
37. [Thrombolytic effect of urokinase upon various methods of administration into the body]. Andreenko GV; Serebriakova TN; Podorol'skaia LV; Afanasenko GA; Liaginskiĭ AV; Raevskaia AK Vopr Med Khim; 1992; 38(1):44-6. PubMed ID: 1441294 [TBL] [Abstract][Full Text] [Related]
38. Effects of a "single shot" of urokinase on fibrinolytic activities in patients with IgA nephropathy. Tomino Y; Miura M; Suga T; Yagame M; Endoh M; Nomoto Y; Sakai H; Itoh K; Ikeda N Tokai J Exp Clin Med; 1984 Mar; 9(1):43-7. PubMed ID: 6535301 [TBL] [Abstract][Full Text] [Related]
39. Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis. de Prost D; Guerot C; Laffay N; Horellou MH; Samama M Thromb Haemost; 1983 Dec; 50(4):792-6. PubMed ID: 6665760 [TBL] [Abstract][Full Text] [Related]
40. Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis. Lee KN; Lee SC; Jackson KW; Tae WC; Schwartzott DG; McKee PA Thromb Haemost; 1998 Oct; 80(4):637-44. PubMed ID: 9798984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]